Dashboard
Manage Tickers

CRBUCaribou Biosciences, Inc.

Nasdaq cariboubio.com


$ 1.85 $ -0.09 (-4.64 %)    

Monday, 12-Aug-2024 15:59:02 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 451.00 $ 0.97 (0.22 %)
DIA $ 393.81 $ -1.38 (-0.35 %)
SPY $ 533.05 $ 0.28 (0.05 %)
TLT $ 96.62 $ 0.35 (0.36 %)
GLD $ 228.41 $ 3.85 (1.71 %)
$ 1.85
$ 1.85 x 1,800
-- x --
-- - --
$ 1.50 - $ 8.33
817,660
na
167.13M
$ 1.85
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 03-11-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-09-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 03-21-2022 12-31-2021 10-K
12 11-09-2021 09-30-2021 10-Q
13 09-02-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

rbc-capital-reiterates-outperform-on-caribou-biosciences-maintains-14-price-target
RBC Capital Reiterates Outperform on Carib...
08/07/2024 15:53:00

RBC Capital analyst Luca Issi reiterates Caribou Biosciences (NASDAQ:CRBU) with a Outperform and maintains $14 price target.

caribou-biosciences-q2-eps-042-beats-045-estimate-sales-346m-beat-304m-estimate
Caribou Biosciences Q2 EPS $(0.42) Beats $...
08/06/2024 21:12:17

Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $...

evaluating-caribou-biosciences-insights-from-4-financial-analysts
Evaluating Caribou Biosciences: Insights F...
07/17/2024 12:00:19

hc-wainwright--co-reiterates-buy-on-caribou-biosciences-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Cari...
07/17/2024 10:12:53

HC Wainwright & Co. analyst Robert Burns reiterates Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $9 price ...

caribou-biosciences-discontinues-preclinical-research-on-allogeneic-car-nk-platform-reduces-workforce-by-21-positions-cost-containment-measures-to-extend-cash-runway-by-at-least-6-months-into-h2-2026
Caribou Biosciences Discontinues Preclinic...
07/16/2024 20:18:16

- Reuters 

cracking-the-code-understanding-analyst-reviews-for-caribou-biosciences
Cracking The Code: Understanding Analyst R...
06/04/2024 13:00:30

hc-wainwright--co-maintains-buy-on-caribou-biosciences-lowers-price-target-to-9
HC Wainwright & Co. Maintains Buy on Carib...
06/04/2024 10:13:37

HC Wainwright & Co. analyst Robert Burns maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and lowers the price tar...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
06/03/2024 16:31:06

caribou-biosciences-announced--clinical-data-from-cb-010-antler-phase-1-trial-in-second-line-lbcl-patients-at-asco-2024-144-months-median-pfs-in-antler-patients-with-partial-hla-matching-4-alleles
Caribou Biosciences Announced Clinical Da...
06/02/2024 23:59:39

attention-biotech-investors---stocks-to-watch-from-rbc-global-healthcare-conference
Attention Biotech Investors - Stocks To Wa...
05/16/2024 18:21:31

RBC's Chris McCarthy discusses biotech investor sentiment at the RBC Global Healthcare Conference. Focused on upcoming bina...

expert-ratings-for-caribou-biosciences
Expert Ratings For Caribou Biosciences
05/16/2024 18:01:25

truist-securities-maintains-buy-on-caribou-biosciences-maintains-19-price-target
Truist Securities Maintains Buy on Caribou...
05/16/2024 17:11:51

Truist Securities analyst Asthika Goonewardene maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $19 pric...

hc-wainwright--co-reiterates-buy-on-caribou-biosciences-maintains-24-price-target
HC Wainwright & Co. Reiterates Buy on Cari...
05/13/2024 17:44:44

HC Wainwright & Co. analyst Robert Burns reiterates Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $24 price...

caribou-biosciences-q1-eps-046-misses-040-estimate-sales-243m-miss-290m-estimate
Caribou Biosciences Q1 EPS $(0.46) Misses ...
05/07/2024 21:16:31

Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of...

caribou-biosciences-to-present-initial-dose-expansion-data-from-cb-010-antler-phase-1-trial-in-rr-b-nhl-at-the-2024-american-society-of-clinical-oncology-annual-meeting
Caribou Biosciences To Present Initial Dos...
04/24/2024 14:03:07

Caribou Biosciences, Inc. (NASDAQ:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announ...

caribou-biosciences-announces-oral-presentation-on-in-vivo-cas12a-chrdna-genome-editing-at-the-27th-annual-meeting-of-asgct
Caribou Biosciences Announces Oral Present...
04/15/2024 13:15:04

Caribou Biosciences, Inc. (NASDAQ:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announ...

kura-sushi-posts-upbeat-sales-joins-caribou-biosciences-krispy-kreme-and-other-big-stocks-moving-higher-in-fridays-pre-market-session
Kura Sushi Posts Upbeat Sales, Joins Carib...
04/05/2024 12:01:39

U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday.

caribou-biosciences-expands-clinical-development-of-cb-010-with-fda-clearance-of-ind-in-lupus
Caribou Biosciences Expands Clinical Devel...
04/04/2024 20:01:12

-- FDA has cleared Caribou's IND application for CB-010 in lupus nephritis and extrarenal lupus; GALLOP Phase 1 clinical tr...

hc-wainwright--co-maintains-buy-on-caribou-biosciences-raises-price-target-to-24
HC Wainwright & Co. Maintains Buy on Carib...
03/19/2024 10:26:13

HC Wainwright & Co. analyst Robert Burns maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and raises the price tar...

investor-sentiment-improves-following-inflation-data-dow-jumps-over-200-points
Investor Sentiment Improves Following Infl...
03/13/2024 08:42:45

The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, but the index remained in the "...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION